Uzedy (risperidone) NDC 51759-740

NDC codes

FDA NDC Directory

Product NDC (as listed)51759-740Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51759-0740Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51759-740-10	51759074010	1 SYRINGE, GLASS in 1 CARTON (51759-740-10) / .42 mL in 1 SYRINGE, GLASSMarketed from May 1, 2023
51759-740-11	51759074011	1 SYRINGE, GLASS in 1 CARTON (51759-740-11) / .42 mL in 1 SYRINGE, GLASSMarketed from May 1, 2023 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Uzedy
Generic name (nonproprietary): risperidone
Active ingredients: Risperidone — 150 mg/.42mL
Dosage form: Injection, Suspension, Extended release
Route: Subcutaneous
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 213586
Marketing start: May 1, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 51759-740_fbc54ee2-4211-4765-a288-75778def0f5aSPL ID fbc54ee2-4211-4765-a288-75778def0f5a
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451759074010 followed by a unit qualifier and the quantity

Package 51759-0740-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under NDA 213586

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 213586
Product	Strength	Form · route	Labeler	Product NDC
Uzedyrisperidone	Risperidone 100 mg/.28mL	Injection, Suspension, Extended releaseSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-520
Uzedyrisperidone	Risperidone 50 mg/.14mL	Injection, Suspension, Extended releaseSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-305
Uzedyrisperidone	Risperidone 75 mg/.21mL	Injection, Suspension, Extended releaseSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-410
Uzedyrisperidone	Risperidone 200 mg/.56mL	Injection, Suspension, Extended releaseSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-850
Uzedyrisperidone	Risperidone 250 mg/.7mL	Injection, Suspension, Extended releaseSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-960
Uzedyrisperidone	Risperidone 125 mg/.35mL	Injection, Suspension, Extended releaseSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-630